Ganciclovir Inhibits Lymphocyte Proliferation by Impairing DNA Synthesis-Reference-Cited by-同舟云学术

Ganciclovir Inhibits Lymphocyte Proliferation by Impairing DNA Synthesis

Published:2007-07 Issue:7 Volume:13 Page:765-770
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Battiwalla Minoo,Wu Yiyuan,Bajwa Rajinder P.S.,Radovic Marija,Almyroudis Nikolaos G.,Segal Brahm H.,Wallace Paul K.,Nakamura Ryotaro,Padmanabhan Swaminathan,Hahn Theresa,McCarthy Philip L.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference24 articles.

1. Risk factors for cytomegalovirus infection after human marrow transplantation;Meyers;J Infect Dis,1986

2. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation;Goodrich;N Engl J Med,1991

3. Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients;Boeckh;Blood,1999

4. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study;Boeckh;Blood,1996

5. Immunosuppressive effects of ganciclovir on in vitro lymphocyte responses;Bowden;J Infect Dis,1987

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges for the improvement of valganciclovir prophylaxis in solid organ transplantation and the possible role of therapeutic drug monitoring in adults;British Journal of Clinical Pharmacology;2024-06-18

2. Development of a highly cytotoxic, clinical-grade virus-specific T cell product for adoptive T cell therapy;Cellular Immunology;2024-01

3. Body surface area compared to body weight dosing of valganciclovir is associated with increased toxicity in pediatric solid organ transplantation recipients;American Journal of Transplantation;2023-12

4. Real-World Experience With CMV inSIGHT T Cell Immunity Testing in High-Risk Kidney and Pancreas Transplant Recipients;Annals of Pharmacotherapy;2023-10-28

5. Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant;Journal of Clinical Investigation;2023-05-15